Filing Details
- Accession Number:
- 0001209191-18-044452
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-30 17:51:10
- Reporting Period:
- 2018-07-30
- Accepted Time:
- 2018-07-30 17:51:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1509190 | Aratana Therapeutics Inc. | PETX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1352447 | Steven Peter St | C/O Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Leawood KS 66211 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-07-30 | 11,513 | $4.33 | 649,233 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 86,997 | Indirect | By LLC |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on September 13, 2017.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Held in the name of Vie Venture LLC, a Delaware limited liability company ("Vie Venture"). The Reporting Person has sole voting and dispositive power over the shares held by Vie Venture, but disclaims beneficial ownership of the shares held thereby except to the extent of his pecuniary interest therein.